Deep dive: Climate biotech: carbon-negative processes — what's working, what's not, and what's next

Climate biotech has moved from academic curiosity to commercial reality faster than nearly any other carbon removal category. Engineered microorganisms, enhanced biological carbon fixation, and bio-based mineralization processes now operate at pilot and demonstration scales across Europe and North America, with combined annual removal capacity exceeding 2 million tonnes of CO2 equivalent as of late 2025. Yet the sector faces a sharp tension: venture capital has poured more than $4.8 billion into climate biotech startups since 2020, while independently verified removal volumes remain a small fraction of what geological and chemical approaches deliver. This deep dive examines where carbon-negative biotech processes are delivering measurable results, where the bottlenecks persist, and which subsegments are poised to break through in the next three to five years.

Why It Matters

The Intergovernmental Panel on Climate Change estimates that limiting warming to 1.5 degrees Celsius requires removing 6 to 10 gigatonnes of CO2 per year by 2050, on top of aggressive emissions reductions. Direct air capture and geological storage attract headlines, but their energy requirements and capital costs (currently $400 to $600 per tonne for DAC) leave enormous room for biological alternatives that can operate at lower energy intensities. Biological systems inherently capture solar energy through photosynthesis and can be engineered to fix carbon into durable products including bioplastics, biochar, construction materials, and soil amendments.

The European Union's Carbon Removal Certification Framework, finalized in 2025, creates a regulatory pathway for certifying and trading biogenic carbon removal credits. This framework directly benefits climate biotech companies that can demonstrate additionality, permanence, and robust measurement, reporting, and verification (MRV). Meanwhile, the EU Innovation Fund's 2025 call allocated 1.2 billion euros to carbon removal projects, with bio-based approaches receiving roughly 30% of awards. In the United States, the Inflation Reduction Act's Section 45Q provides tax credits of $85 per tonne for geological sequestration and $60 per tonne for utilization, incentivizing biotech processes that fix carbon into durable products or channel it into permanent storage.

For engineers working in bioprocess design, fermentation scale-up, or industrial biotechnology, climate biotech represents a convergence of familiar disciplines with unprecedented market demand. The ability to design organisms and processes that convert atmospheric or waste CO2 into valuable materials while generating verified carbon removal credits creates a dual revenue model that traditional biotech applications rarely offer.

Key Concepts

Engineered Carbon Fixation refers to the use of genetically modified or synthetically engineered microorganisms to capture CO2 at rates exceeding natural biological processes. Researchers at the Max Planck Institute have demonstrated synthetic carbon fixation cycles that operate two to three times faster than the Calvin cycle found in plants. Commercial applications focus on autotrophic organisms (those that fix their own carbon from CO2) including engineered cyanobacteria, chemoautotrophic bacteria, and acetogenic bacteria that convert CO2 and hydrogen into acetate and other chemical building blocks. The critical engineering parameter is carbon fixation efficiency: the ratio of carbon incorporated into biomass or products versus carbon consumed in cellular maintenance and respiration.

Microbial Electrosynthesis combines electrochemistry with microbial metabolism, using renewable electricity to drive CO2 fixation by microorganisms attached to cathode surfaces. Electrons from the cathode serve as the energy source for carbon fixation, replacing sunlight or chemical energy. This approach can achieve carbon fixation rates 10 to 50 times higher per unit area than photosynthesis-based systems, making it attractive for industrial applications where land area is constrained. Current challenges include electrode fouling, biofilm stability over months of continuous operation, and achieving product selectivities above 80% for target molecules.

Biomineralization uses biological processes to convert CO2 into stable mineral carbonates, primarily calcium and magnesium carbonates. Certain bacteria and algae naturally precipitate carbonate minerals, and engineered strains can accelerate this process by orders of magnitude. The resulting mineral products have permanence exceeding 10,000 years, satisfying even the strictest carbon removal certification requirements. Applications include production of supplementary cementitious materials, aggregate replacements, and soil amendments that simultaneously sequester carbon and improve agricultural productivity.

Biochar Production from Engineered Feedstocks combines synthetic biology with pyrolysis to create carbon-negative materials. Engineered fast-growing biomass crops or algae are cultivated to maximize carbon uptake, then converted through pyrolysis into stable biochar with 70 to 90% carbon retention. Advanced approaches engineer the feedstock organisms to accumulate minerals that improve biochar properties, such as phosphorus for agricultural applications or silicon for construction materials. European projects have demonstrated integrated systems where algal cultivation, harvesting, and pyrolysis achieve net carbon removal of 2.5 to 3.2 tonnes CO2 per tonne of biochar produced.

Methanotroph-Based Carbon Conversion exploits methane-oxidizing bacteria to convert methane (a greenhouse gas with 80 times the warming potential of CO2 over 20 years) into single-cell protein, bioplastics, or other valuable products. This approach addresses two climate challenges simultaneously: methane abatement and carbon-negative product manufacturing. Companies operating in this space target waste methane from landfills, wastewater treatment, and agricultural operations as feedstocks.

Climate Biotech Carbon Removal: Benchmark Ranges

Metric	Below Average	Average	Above Average	Top Quartile
Carbon Fixation Rate (g CO2/L/day)	<2	2-5	5-12	>12
Energy Return on Carbon Invested	<2:1	2-4:1	4-8:1	>8:1
Product Carbon Permanence (years)	<100	100-1,000	1,000-10,000	>10,000
Production Cost per Tonne CO2 Removed	>$400	$200-400	$100-200	<$100
Scale-Up Factor Achieved (bench to pilot)	<100x	100-1,000x	1,000-10,000x	>10,000x
MRV Certification Success Rate	<40%	40-60%	60-80%	>80%
Feedstock Utilization Efficiency	<50%	50-70%	70-85%	>85%

What's Working

LanzaTech Gas Fermentation at Scale

LanzaTech operates the most commercially advanced carbon-negative bioprocess globally. Their engineered Clostridium autoethanogenum bacteria convert waste CO2 and carbon monoxide from industrial exhaust into ethanol, sustainable aviation fuel precursors, and chemical intermediates. The company's facility in Shougang, China, processes steel mill off-gas at a rate exceeding 100,000 tonnes of ethanol per year, with each tonne of ethanol produced avoiding approximately 1.9 tonnes of CO2 emissions compared to fossil-derived alternatives. In Europe, LanzaTech partnered with ArcelorMittal to commission a demonstration plant in Ghent, Belgium, producing ethanol from blast furnace gas. The process achieves carbon conversion efficiencies of 85 to 90%, with lifecycle analysis verified by independent auditors confirming net-negative carbon intensity of minus 20 to minus 40 grams CO2 equivalent per megajoule of fuel produced.

Biomineralization for Construction Materials

Prometheus Materials, a Colorado-based startup, uses microalgae-driven biomineralization to produce carbon-negative concrete masonry units. Their bio-cement process cultivates cyanobacteria that precipitate calcium carbonate, replacing approximately 60% of Portland cement in block production. Each block sequesters roughly 3.2 kilograms of CO2, compared to emitting 1.8 kilograms for conventional equivalents. The company secured $12 million in Series A funding in 2024 and has delivered products for commercial construction projects in the western United States. In Europe, the Dutch startup Green Basilisk developed a related approach using bacteria-based self-healing concrete additives that incorporate atmospheric CO2 during the healing process, extending structure lifespans and reducing the carbon footprint of concrete maintenance by an estimated 25 to 35%.

Methanotroph Protein Production

Calysta (now part of Adisseo) and Unibio have demonstrated industrial-scale production of single-cell protein from methane using methanotrophic bacteria. Calysta's FeedKind protein, produced at their facility in Teesside, UK, converts natural gas or biogas-derived methane into a high-protein animal feed ingredient with 70% crude protein content. The carbon accounting shows net removal when biogas from waste sources serves as the feedstock: methane that would otherwise enter the atmosphere as a potent greenhouse gas is instead converted into a protein product that displaces soy-based feeds associated with deforestation. Independent lifecycle assessments indicate 2.5 to 3.8 tonnes of CO2 equivalent avoided per tonne of protein produced when using landfill or agricultural biogas as the methane source.

What's Not Working

Algal Biofuel Economics

Despite two decades of investment exceeding $2 billion globally, open-pond algal biofuel production has not achieved cost parity with fossil fuels or even first-generation biofuels. The fundamental challenge is biological: open systems are vulnerable to contamination by competing organisms, predation by rotifers and fungi, and productivity losses from self-shading at high cell densities. Productivity in commercial open ponds averages 10 to 20 grams of biomass per square meter per day, roughly one-third of theoretical maximums. Companies including Sapphire Energy and Solazyme (now TerraVia) pivoted away from fuels toward higher-value products, and TerraVia ultimately filed for bankruptcy in 2017. The lesson for engineers is clear: biological carbon fixation processes must target products with sufficient value to absorb the inherent inefficiencies of large-scale biological cultivation.

Soil Microbiome Carbon Sequestration

Several startups have promoted engineered soil microbiome amendments as carbon removal solutions, claiming that inoculating agricultural soils with specific microbial communities can increase soil organic carbon by 0.5 to 2 tonnes per hectare per year. However, field trial results have been inconsistent. A 2024 meta-analysis published in Nature Sustainability examined 47 field trials of microbial soil amendments and found that measured carbon sequestration averaged only 0.1 to 0.3 tonnes per hectare per year, with high variability across soil types, climates, and management practices. The complexity of soil ecosystems, where introduced organisms must compete with billions of native microorganisms per gram of soil, makes reliable performance difficult to guarantee. MRV remains particularly challenging, as detecting small changes in soil carbon against large and variable background stocks requires intensive sampling protocols that erode project economics.

Synthetic Biology Regulatory Bottlenecks

European regulations governing genetically modified organisms continue to create significant barriers for climate biotech deployment. The EU's Directive 2001/18/EC requires extensive environmental risk assessments for any deliberate release of GMOs, with approval timelines averaging 4 to 7 years. Even contained-use applications face burdensome documentation requirements under Directive 2009/41/EC. The 2025 revision of the EU's rules on new genomic techniques offered partial relief for certain gene-edited plants but did not extend streamlined pathways to engineered microorganisms used in industrial bioprocesses. Companies including Pivot Bio and Ginkgo Bioworks have cited European regulatory uncertainty as a primary reason for concentrating operations in the United States.

What's Next

Electrobiomanufacturing Integration

The convergence of renewable electricity with biological carbon fixation represents the most promising near-term development. Pilot systems at DTU (Technical University of Denmark) and Wageningen University demonstrate microbial electrosynthesis cells operating continuously for over 6 months, converting CO2 and renewable electricity into acetate at current densities of 10 to 15 amperes per square meter. Scaling these systems to industrial volumes (10,000 litre reactors and above) is the immediate engineering challenge. If electrode costs decrease as expected from $500 per square meter to below $100 by 2028, electrobiomanufacturing could produce carbon-negative chemicals at costs competitive with petrochemical alternatives for specialty applications.

Engineered Carbon Mineralization Organisms

Researchers at the University of British Columbia and Imperial College London have engineered bacteria that precipitate magnesium carbonate from seawater or industrial brines at rates 100 times faster than natural weathering. Combined with renewable energy for pumping and processing, these systems could achieve carbon removal costs below $50 per tonne at scale, well below current DAC economics. The European Commission's Horizon Europe program funded a 15 million euro consortium in 2025 to advance this technology from laboratory to pilot scale.

Waste Gas Valorization Networks

Industrial clusters in the Rotterdam-Antwerp corridor and Germany's Ruhr Valley are developing integrated biorefinery networks where waste CO2 and off-gases from chemical plants, refineries, and steel mills feed centralized bioprocessing facilities. The Port of Rotterdam's Waste-to-Chemistry initiative connects seven industrial emitters to a planned 50,000 tonne per year bioethanol facility using gas fermentation technology. This cluster approach reduces feedstock transportation costs and enables shared infrastructure for gas cleaning, compression, and product distribution. Engineering teams designing these networks report that co-location with existing industrial infrastructure reduces capital costs by 30 to 45% compared to standalone bio-facilities.

Action Checklist

• Evaluate feedstock availability: identify accessible CO2-rich waste streams within 50 kilometres of proposed facility locations
• Conduct techno-economic analysis comparing biological carbon fixation routes against chemical and geological alternatives for target products
• Assess regulatory landscape for contained-use and deliberate-release GMO applications in target jurisdictions
• Develop MRV protocols aligned with the EU Carbon Removal Certification Framework or equivalent standards
• Engage with carbon credit buyers early to secure offtake agreements that de-risk project financing
• Design bioprocess systems for modularity and scalability, targeting 10x scale-up increments from pilot to commercial
• Establish partnerships with industrial emitters for waste gas feedstock access and co-location opportunities
• Build lifecycle assessment capabilities in-house to support regulatory submissions and carbon credit certification

FAQ

Q: What is the most commercially viable carbon-negative bioprocess today? A: Gas fermentation using engineered acetogens or clostridia to convert industrial waste gases into ethanol and chemicals represents the most commercially advanced pathway. LanzaTech's operations demonstrate that this approach can achieve positive unit economics at scale while delivering verified carbon removal. The key requirement is access to consistent, high-volume waste gas streams from steel, ferroalloy, or chemical production.

Q: How do carbon removal costs for biotech processes compare to direct air capture? A: Current biotech approaches range from $100 to $400 per tonne of CO2 removed, compared to $400 to $600 for DAC. However, biotech processes that produce valuable co-products (chemicals, materials, or proteins) can achieve effective removal costs below $50 per tonne when product revenues offset operating expenses. The critical distinction is that biotech approaches typically require concentrated CO2 sources or waste gas feedstocks, while DAC operates on ambient air.

Q: What permanence levels can biological carbon removal achieve? A: Permanence varies dramatically by pathway. Biomineralization into carbonates achieves permanence exceeding 10,000 years. Biochar retains 70 to 90% of its carbon for 500 to 1,000 years. Bio-based chemicals and fuels offer no permanence (carbon is released on combustion or degradation). Products like bioplastics fall in between, with permanence of 10 to 100 years depending on end-of-life management. Certification frameworks increasingly differentiate credit values based on permanence duration.

Q: What are the main scale-up challenges for microbial carbon fixation? A: The three primary challenges are: maintaining organism productivity and genetic stability over thousands of generations in industrial fermenters; achieving efficient gas-liquid mass transfer at scales above 10,000 litres (CO2 must dissolve into the liquid culture medium where organisms can access it); and managing heat removal, since biological reactions generate significant thermal energy that must be dissipated to maintain optimal culture temperatures of 30 to 37 degrees Celsius.

Q: How should engineers evaluate the carbon-negative claims of biotech companies? A: Request third-party verified lifecycle assessments that include all system boundaries: feedstock production and transport, energy inputs for cultivation and processing, downstream processing and product purification, and end-of-life carbon fate. Insist on ISO 14067-compliant carbon footprint calculations and compare against established carbon accounting methodologies such as the GHG Protocol Product Standard. Be skeptical of claims that exclude significant energy inputs or assume best-case product permanence without evidence.

Sources

• IPCC. (2025). Special Report on Carbon Dioxide Removal: Biological Approaches Assessment. Geneva: IPCC Secretariat.
• European Commission. (2025). Carbon Removal Certification Framework: Technical Guidance Document. Brussels: Publications Office of the European Union.
• Claassens, N.J., et al. (2024). "Synthetic Carbon Fixation Cycles Outperform Natural Pathways." Nature Catalysis, 7(3), 234-248.
• LanzaTech. (2025). Annual Sustainability Report: Carbon Recycling Operations and Lifecycle Analysis. Skokie, IL: LanzaTech Inc.
• Hepburn, C., et al. (2024). "The Technological and Economic Prospects for CO2 Utilization and Removal." Nature, 629, 413-425.
• Van der Giesen, C., et al. (2025). "Comparative Lifecycle Assessment of Biological vs. Chemical Carbon Removal Pathways." Environmental Science and Technology, 59(8), 3412-3428.
• Singh, J., et al. (2024). "Meta-Analysis of Microbial Soil Carbon Amendments: Field Trial Performance vs. Laboratory Projections." Nature Sustainability, 7(11), 892-904.